Connor, Clark & Lunn Investment Management (CC&L)’s FibroGen FGEN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,163
| Closed | -$25.9K | – | 1512 |
|
|
2024
Q2 | $25.9K | Buy |
+1,163
| New | +$25.9K | ﹤0.01% | 1341 |
|
|
2023
Q4 | – | Sell |
-4,378
| Closed | -$94.4K | – | 1433 |
|
|
2023
Q3 | $94.4K | Buy |
+4,378
| New | +$94.4K | ﹤0.01% | 1295 |
|
|
2023
Q2 | – | Sell |
-1,070
| Closed | -$499K | – | 1371 |
|
|
2023
Q1 | $499K | Buy |
+1,070
| New | +$499K | ﹤0.01% | 882 |
|
|
2022
Q3 | – | Sell |
-471
| Closed | -$124K | – | 1153 |
|
|
2022
Q2 | $124K | Sell |
471
-1,368
| -74% | -$360K | ﹤0.01% | 970 |
|
|
2022
Q1 | $553K | Sell |
1,839
-814
| -31% | -$245K | ﹤0.01% | 768 |
|
|
2021
Q4 | $935K | Buy |
2,653
+1,534
| +137% | +$541K | ﹤0.01% | 690 |
|
|
2021
Q3 | $286K | Buy |
1,119
+442
| +65% | +$113K | ﹤0.01% | 884 |
|
|
2021
Q2 | $451K | Sell |
677
-687
| -50% | -$458K | ﹤0.01% | 805 |
|
|
2021
Q1 | $1.18M | Buy |
1,364
+148
| +12% | +$128K | 0.01% | 666 |
|
|
2020
Q4 | $1.13M | Buy |
+1,216
| New | +$1.13M | 0.01% | 612 |
|
|
2019
Q4 | – | Sell |
-466
| Closed | -$431K | – | 980 |
|
|
2019
Q3 | $431K | Buy |
+466
| New | +$431K | ﹤0.01% | 715 |
|
|
2016
Q1 | – | Sell |
-1,208
| Closed | -$920K | – | 855 |
|
|
2015
Q4 | $920K | Sell |
1,208
-176
| -13% | -$134K | 0.01% | 455 |
|
|
2015
Q3 | $758K | Buy |
+1,384
| New | +$758K | 0.01% | 450 |
|